The global single-cell omics market is expected to be valued at US$ 3.6 billion in 2024. The market is projected to grow at a CAGR of 19.5% over the forecast period. By 2034, the market value is expected to hit US$ 21.3 billion.
The single-cell omics market is expected to experience significant growth in the coming years, driven by a range of factors. The increasing demand for research and development activities aimed at developing effective cancer therapies is driving the market. With rising concerns regarding cancer worldwide, single-cell omics has become an essential tool in reducing the complexity of tumors.
Request A Sample Copy of This Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-19259
There is a growing interest in biotechnology research, which is expected to fuel market demand in the future. The versatility of omics technology, which allows for the analysis of various applications such as brain science, tumor immunology, and pre-implantation, is also contributing to the growth of the market.
The rising demand for the analysis of gene expression differences in individual cells, particularly for the understanding of intra-tumoral heterogeneity. Governments around the world are also increasingly funding research and development for the life sciences, further driving the growth of the single cell omics market. The need for precision medicine for targeted therapies is also expected to drive the global demand for single cell omics. With increasing activities regarding drug discoveries and personalized medicines, the market is anticipated to witness substantial growth in the coming years.
“The need for precision medicine for targeted therapies is also expected to drive the demand for single cell omics. With increasing activities regarding drug discoveries and personalized medicines, the market is anticipated to witness substantial growth in the coming years,” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).
Key Takeaways from the Single Cell Omics Market:
- The single cell omics market is estimated to register a CAGR of 19.5% and reach a valuation of US$ 21.3 billion by 2034.
- The single-cell genomics segment is anticipated to dominate the market and expand at a 19.3% market CAGR from 2024 to 2034.
- With a 19.1% market CAGR, the oncology segment is expected to drive the global market through 2024 to 2034.
Competitive Landscape:
The market is a dynamic and fiercely competitive, with a range of players offering both branded and generic drugs to consumers. The market is shaped by various factors such as government regulations, patent expirations, and advancements in drug development technology. With an increasing number of elderly individuals and a growing incidence of chronic pain conditions, the market is predicted to continue its upward trajectory in the years to come.
Recent Development:
In 2023, A life sciences company based in California, Singular Genomics Systems, Inc., has introduced its Max read kits for single cell applications on the G4 sequencing platform. The company is renowned for its innovative sequencing technologies that are developed for genomic and transcriptomic analysis. The latest addition to its repertoire is expected to cater to the rising demand for high-throughput single-cell sequencing.
Request Methodology Now: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-19259
Key Market Players:
- Mission Bio
- RareCyte, Inc.
- Cytena
- WaferGen Bio-systems
- Dolomite Bio
- Menarini Silicon Biosystems
- NanoCellect Biomedical
- Sphere Fluidics
- 1CellBio
- OnRamp Bioinformatics
- 10x Genomics
- Illumina
- Thermo Fisher Scientific
- Fluidigm Corporation
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Takara Bio, Inc.
- QIAGEN
- Norgen Biotek Corp.
- Fluxion Biosciences, Inc.
Key Market Segmentation:
By Product Type:
- Single-cell Genomics
- Single-cell Transcriptomics
- Single-cell Proteomics
- Single-cell Metabolomics
By Application:
- Oncology
- Cell Biology
- Neurology
- Immunology
- Other Applications
By End User:
- Academic and Research Organizations
- Pharmaceutical & Biotechnology Companies
- Hospital and Diagnostic Laboratories
- Other End-Users
By Region:
- North America
- Latin America
- East Asia
- South Asia
- Europe
- Oceania
- MEA
Request Purchase on Report: https://www.futuremarketinsights.com/checkout/19259
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain:
Single Cell Analysis System Market Size: The global single cell analysis system market was valued at US$ 3.4 Billion in 2023 and is expected to reach US$ 7.2 Billion by 2033 grow at a CAGR of 7.8%.
Nutragenomics Market Share: The global nutragenomics market size is expected to reach US$ 2.11 Billion in 2032. The nutragenomics market is growing rapidly. As per FMI Analysts, the global Nutragenomics market is estimated to be valued at US$ 538.90 Million in 2022 and is projected to increase at a CAGR of 16.48% in the forecast period from 2022 to 2032.
Cataract Surgery Device Market Demand: The cataract surgery device market has exhibited an ascending trend, where its value is estimated to go from US$ 8,928 million in 2024 to US$ 12,472.70 million in 2034. Adoption of cataract surgery devices is exhibiting a growth rate of 3.40% from 2024 to 2034.
Ibuprofen API Market Growth: Recently proposed data on the ibuprofen API market analysis demonstrates that demand for ibuprofen APIs is valued at around US$ 665 million in 2024 and is on its way to register a CAGR of 2.5% to reach US$ 851 million by 2034.
Mobile Cardiac Telemetry System Market Trends: In a recently updated edition, trends infer a valuation of US$ 1,175.10 million for the mobile cardiac telemetry system market in 2024. Looking ahead to 2034, the current forecast projects a CAGR of 8.30%. Current projections of mobile cardiac telemetry device market imply a valuation of US$ 2,608.30 million by 2034.
Anti-aging Product Service and Device Market Outlook: As per the FMI’s revised market report, sales of anti-aging product services and devices accumulate a present valuation of US$ 60,764.40 million in 2024. Going by this trend, the anti-aging product service market amplifies and equates to a market worth US$ 1,01,843.40 million, with a steady CAGR of 5.30% by 2034.
Molecular Diagnostic Market Overview: Current projections of molecular diagnostic market indicate an estimation of US$ 60,347.40 million by 2034, climbing up from US$ 39,611.00 million in 2024. After an exhaustive assessment of the market, a moderate CAGR of 4.30% is envisaged through 2034.
Home Sleep Screening Device Market Development: In 2024, the global home sleep screening device market was valued at US$ 3,763.10 million. According to current estimations, the home sleep screening device market may garner a moderate CAGR of 4.30% from 2024 to 2034. By 2034, the market may reach a valuation of US$ 5,733.10 million by 2034.
Non Surgical Fat Reduction Market Forecast: In the updated report by Future Market Insights, The non surgical fat reduction market is set to rise at a CAGR of 5.60% through 2034. The market value is slated to increase from US$ 1700.5 million in 2024 to US$ 2932.3 million by 2034.
Dosimetry Market Opportunity: In a recently updated edition of the dosimetry market, FMI has assessed the market valuation to be US$ 3,144.10 million in 2024. The market is bidding for a valuation of US$ 4,882.60 million by 2034, expanding at an average 4.5% growth rate.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube